Health Research Services (HRS) Ltd. was founded in 2000 and run offices in UK, Germany, Moscow, Kiev and Warsaw. HRS is an independent contract research organisation offering specialist services in the areas of Scientific Drug Research & Development, Project Management, Clinical Monitoring, Medical Writing.

HRS provides expert services to turn basic research on promising new drug candidates into marketed medications.

Recent projects include the re-approval and marketing authorisation from German regulatory authorities (BfArM) of a herbal medicinal product which has been classified as a NCE and the notification from the FDA in the US where it is available since 2010. The preclinical and clinical research and development programme for this medication was set-up in 2002 and conducted by HRS on behalf of the pharmaceutical manufacturer, and this product is now marketed abroad world-wide by HRS GmbH, another company of HRS.

HRS developed the patent applications for the use of this medication for additional indications.

HRS is a member of the Federal Association of Contract Research Organisations in Germany (Bundesverband medizinischer Auftragsinstitute e.V., BVMA). HRS has been audited by the BVMA in 2005, 2008 and 2011.